US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist
  • 1.450
  • +0.005+0.35%
Close Jul 23 16:00 ET
56.60MMarket Cap-792P/E (TTM)

About Barinthus Biotherapeutics Company

Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.

Company Profile

SymbolBRNS
Company NameBarinthus Biotherapeutics
Listing DateApr 30, 2021
Issue Price17.00
Founded2021
CEOMr. William J. Enright
MarketNASDAQ
Employees98
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressZeus Building,Rutherford Avenue,Unit 6-10, Harwell
CityDidcot
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX11 0DF
Phone44-18-6581-8808

Company Executives

  • Name
  • Position
  • Salary
  • William J. Enright
  • Chief Executive Officer and Director
  • 1.81M
  • Dr. Nadege Pelletier, PhD
  • Chief Scientific Officer
  • 1.67M
  • Gemma Brown
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Graham Griffiths
  • Chief Business Officer
  • 731.06K
  • Robin Wright
  • Chairman of the Board
  • 117.13K
  • Dr. Alex Hammacher
  • Director
  • 71.11K
  • Dr. Anne M. Phillips, M.D.
  • Independent Director
  • 81.06K
  • Dr. Pierre A. Morgon, Pharm.D.
  • Independent Director
  • 85.42K
  • Dr. Joseph C.F. Scheeren, B.S.,M.Sc.,Pharm.D.
  • Independent Director
  • 79.82K
  • Karen T. Dawes, M.A.
  • Independent Director
  • 81.69K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg